Search

Displaying results 1651 - 1660 of 10000 in total
  1. Drug

    Cloperastine

    go.drugbank.com/drugs/DB09002
    Investigational

    Cloperastine is a cough suppressant that acts on the central nervous system.

    Categories: Cough and Cold PreparationsProducts: RASITIN TABLET 10MG, COPASTIN FILM COATED TABLET 10MG
  2. Indication

    Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    go.drugbank.com/conditions/DBCOND0069854
    Drugs: Abiraterone · Cabazitaxel · Enzalutamide · Lutetium Lu-177 vipivotide tetraxetan · Niraparib · Olaparib +4 more
    Synonyms: Metastasis from hormone-refractory prostate cancer, Metastasis from hormone-refractory prostate cancer (disorder)
  3. Drug

    Cefdinir

    go.drugbank.com/drugs/DB00535
    ApprovedInvestigational

    Cefdinir was approved by the FDA in 1997 to treat a variety of mild to moderate infections and was initially marketed by Abbvie. … It has been proven to be effective for the treatment of common bacterial infections in the ear, sinus, throat, lungs, and skin.

    Products: ASEMAX 250MG/5ML ORAL SUSPANSIYON HAZIRLAMAK ICIN KURU TOZ, 100ML, MENACEF 250MG/5ML ORAL SÜSPANSIYON HAZIRLAMAK İÇİN KURU TOZ, (100 mL) 1 ŞIŞE
  4. Drug

    Ethambutol

    go.drugbank.com/drugs/DB00330
    ApprovedInvestigational

    Ethambutol is a bacteriostatic agent indicated alongside medications such as [isoniazid], [rifampin], and [pyrazinamide] in the treatment of pulmonary tuberculosis.

    Categories: ethambutol and isoniazid, rifampicin, ethambutol and isoniazidProducts: Myambutol Tab 100mg
  5. Drug

    NRC-AN-019

    go.drugbank.com/drugs/DB17110
    Experimental

  6. Drug

    Oxeladin

    go.drugbank.com/drugs/DB04822
    ApprovedWithdrawn

    Withdrawn from the Canadian, US, and UK markets in 1976 due to carcinogenicity.

    Categories: Cough and Cold Preparations
  7. Drug

    Nialamide

    go.drugbank.com/drugs/DB04820
    ApprovedWithdrawn

    Withdrawn from the Canadian, US, and UK markets in 1963 due to interactions with food products containing tyrosine.

  8. Drug

    Etrasimod

    go.drugbank.com/drugs/DB14766
    ApprovedInvestigational

    This approval was based on favorable results obtained from Pfizer’s Elevate UC Phase III registrational program, consisting of the Elevate UC 52 and Elevate UC 12 clinical trials, that investigates the … efficacy of a 2-mg daily dose regimen of etrasimod, with a 32% and 26% remission rate observed in UC 52 and UC 12 trials respectively.

    Categories: Antineoplastic and Immunomodulating Agents
  9. Drug

    Cefepime

    go.drugbank.com/drugs/DB01413
    ApprovedInvestigational

    [A2457,A249050] Cefepime is normally used to treat severe nosocomial pneumonia and infections caused by multi-resistant microorganisms such as _Pseudomonas aeruginosa_, and is also indicated for the empirical … Cefepime is active against Gram-positive and Gram-negative bacteria, and has greater activity against both compared to third-generation antibiotics.

    Categories: cefepime and amikacinProducts: Cefepime Hydrochloride and Dextrose
  10. Drug

    Dantron

    go.drugbank.com/drugs/DB04816
    ApprovedWithdrawn

    Withdrawn from the Canadian, US, and UK markets in 1998 due to genotoxicity.

    Categories: Alimentary Tract and Metabolism